1. Risk adjustment for health care financing in chronic disease: what are we missing by failing to account for disease severity?
- Author
-
Renee A. Penaloza, Mark D. Eisner, R. Adams Dudley, Irina Tolstykh, Edward H. Yelin, Carlos Iribarren, Paul D. Blanc, Theodore A. Omachi, and Steven E. Gregorich
- Subjects
Gerontology ,Male ,Severity of Illness Index ,Body Mass Index ,Pulmonary Disease, Chronic Obstructive ,Models ,Forced Expiratory Volume ,Prospective Studies ,Prospective cohort study ,Lung ,health care economics and organizations ,COPD ,Age Factors ,Middle Aged ,health care markets ,Incentive ,Models, Economic ,Respiratory ,Income ,Health Policy & Services ,Public Health and Health Services ,Risk Adjustment ,Female ,Diagnosis code ,Adult ,medicine.medical_specialty ,Chronic Obstructive ,Chronic Obstructive Pulmonary Disease ,MEDLINE ,health care reform ,Economic ,socioeconomic factors ,Article ,Pulmonary Disease ,Sex Factors ,risk adjustment ,Clinical Research ,Severity of illness ,medicine ,health care costs ,Humans ,Intensive care medicine ,Aged ,business.industry ,Public Health, Environmental and Occupational Health ,medicine.disease ,financing ,United States ,Good Health and Well Being ,Applied Economics ,Chronic Disease ,Exercise Test ,Health care reform ,Health Expenditures ,business ,Body mass index - Abstract
BACKGROUND:: Adjustment for differing risks among patients is usually incorporated into newer payment approaches, and current risk models rely on age, sex, and diagnosis codes. It is unknown the extent to which controlling additionally for disease severity improves cost prediction. Failure to adjust for within-disease variation may create incentives to avoid sicker patients. We address this issue among patients with chronic obstructive pulmonary disease (COPD). METHODS:: Cost and clinical data were collected prospectively from 1202 COPD patients at Kaiser Permanente. Baseline analysis included age, sex, and diagnosis codes (using the Diagnostic Cost Group Relative Risk Score) in a general linear model predicting total medical costs in the following year. We determined whether adding COPD severity measures - forced expiratory volume in 1 second, 6-Minute Walk Test, dyspnea score, body mass index, and BODE Index (composite of the other 4 measures) - improved predictions. Separately, we examined household income as a cost predictor. RESULTS:: Mean costs were $12,334/y. Controlling for Relative Risk Score, each 1/2 SD worsening in COPD severity factor was associated with $629 to $1135 in increased annual costs (all P
- Published
- 2013
- Full Text
- View/download PDF